← Back to Patent Explorer
US4493829A Expired / Lapsed US ⏱️ 0.0 years remaining

Bio-available succinylated protein-iron derivatives which do not cause gastric lesions, method of preparation and related pharmaceutical compounds

Assignee: Italfarmaco SpA
•
Filing: 1983-02-24
•
Granted: 1985-01-15
•
Expires: 2003-02-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to succinylated proteins, with a degree of succinylation of between 20 to 100%, containing from 0.1 to 20% by weight of iron, obtained by treating succinylated proteins with iron salts in suitable pH ranges. The compounds in question, which are completely tolerated, are characterized by an optimum bioavailability of iron.

Inventors

  • 👤 Giancarlo Sportoletti
  • 👤 Piergiuseppe Pagella
  • 👤 Pietro Cremonesi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 12:02
CPC Classifications
C; C07; C07K; C07K1/00; C07K1/02; C07K14/00; C07K14/415; A; A61; A61P; A61P7/00; A61P7/06; C07K1/107; C07K1/1072; C07K1/1077; C07K1/14; C07K1/30; C07K14/435; C07K14/46; C07K14/47; C07K14/76; C07K14/77; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/832; Y10S530/843; Y10S530/846

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 17 words
A bio-available succinyl ferro-protein derivative obtained by reacting a succinylated animal or vegetable protein with ferro ions.
Claim 2
Dependent Claim 17 words
A bio-available succinyl ferro-protein derivative obtained by reacting a succinylated animal or vegetable protein with ferro ions.
Claim 3
Dependent Claim 19 words
A bio-available succinyl ferro-protein derivative according to claim 1 in which the ferro content is about 0.1-20% by weight.
Claim 4
Dependent Claim 24 words
A bio-available succinyl ferro-protein derivative according to claim 2 in which the degree of succinylation of the protein is from about 20 to 100%.
Claim 5
Dependent Claim 29 words
A bio-available succinyl ferro-protein derivative according to claim 3 in which the degree of succinylation is greater than 70% and the ferro content is greater than 4% by weight.
Claim 6
Dependent Claim 17 words
A bio-available succinyl ferro-protein derivative according to claim 4 in which the protein is a milk protein.
Claim 7
Dependent Claim 17 words
A bio-available succinyl ferro-protein derivative according to claim 4 in which the protein is an ovalbumin protein.
Claim 8
Dependent Claim 17 words
A bio-available succinyl ferro-protein derivative according to claim 4 in which the protein is a soya protein.
Claim 9
Independent Claim 51 words
A method for preparing a bio-available succinyl ferro-protein derivative which comprises reacting a succinylated animal or vegetable protein with a ferro salt in an aqueous medium at a pH of about 2-10 and isolating the resultant reaction product by precipitation at a pH of about 2-4 produced spontaneously or by acidification.
Claim 10
Independent Claim 51 words
A method for preparing a bio-available succinyl ferro-protein derivative which comprises reacting a succinylated animal or vegetable protein with a ferro salt in an aqueous medium at a pH of about 2-10 and isolating the resultant reaction product by precipitation at a pH of about 2-4 produced spontaneously or by acidification.
Claim 11
Dependent Claim 26 words
A method according to claim 8 in which the reaction between the succinylated protein and the ferro salt is conducted at a pH of about 7.
Claim 12
Independent Claim 50 words
A method for preparing a bio-available succinyl ferro-protein derivative which comprises reacting a succinylated animal or vegetable protein with a ferro salt in an aqueous medium at a pH of about 2-10 and isolating the resultant reaction product by separating the aqueous medium after adjusting the pH to about 7.
Claim 13
Independent Claim 50 words
A method for preparing a bio-available succinyl ferro-protein derivative which comprises reacting a succinylated animal or vegetable protein with a ferro salt in an aqueous medium at a pH of about 2-10 and isolating the resultant reaction product by separating the aqueous medium after adjusting the pH to about 7.
Claim 14
Dependent Claim 36 words
A pharmaceutical composition for treating sideropenic anaemia in animals and humans containing as the active ingredient an effective amount of a bio-available succinyl ferro animal or vegetable protein derivative in admixture with a pharmaceutically acceptable carrier.
Claim 15
Dependent Claim 36 words
A pharmaceutical composition for treating sideropenic anaemia in animals and humans containing as the active ingredient an effective amount of a bio-available succinyl ferro animal or vegetable protein derivative in admixture with a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

US2932589A Cited
US3756682A Cited
US3873296A Cited
US3712865A Cited
US3764711A Cited
US4017605A Cited
US4020158A Cited
US4208405A Cited
US4172072A Cited
US4216144A Cited
US4411915A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-01-15 1988-07-16 1989-01-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-01-15 1992-07-16 1993-01-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-01-15 1996-07-16 1997-01-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag